N Balitrand

2.2k total citations
57 papers, 1.7k citations indexed

About

N Balitrand is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, N Balitrand has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 27 papers in Hematology and 14 papers in Genetics. Recurrent topics in N Balitrand's work include Retinoids in leukemia and cellular processes (36 papers), Acute Myeloid Leukemia Research (17 papers) and Estrogen and related hormone effects (12 papers). N Balitrand is often cited by papers focused on Retinoids in leukemia and cellular processes (36 papers), Acute Myeloid Leukemia Research (17 papers) and Estrogen and related hormone effects (12 papers). N Balitrand collaborates with scholars based in France, United States and Israel. N Balitrand's co-authors include Christine Chomienne, L Degos, Sylvie Castaigné, Laurent Delva, Pierre Fenaux, Y Najean, Jean Bastié, Fabien Guidez, Cécile Rochette‐Egly and A Faille and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

N Balitrand

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N Balitrand France 24 1.3k 929 308 291 276 57 1.7k
Marina R. Carpinelli Australia 15 855 0.7× 484 0.5× 120 0.4× 26 0.1× 258 0.9× 30 1.5k
Mack Mabry United States 19 1.2k 0.9× 611 0.7× 109 0.4× 14 0.0× 111 0.4× 31 1.8k
B Hazelton United States 13 240 0.2× 793 0.9× 114 0.4× 16 0.1× 172 0.6× 17 1.2k
Dapeng Wang United States 19 494 0.4× 241 0.3× 102 0.3× 18 0.1× 571 2.1× 44 1.4k
Janet Glassford United Kingdom 16 972 0.8× 193 0.2× 72 0.2× 11 0.0× 302 1.1× 22 1.5k
C C Reynolds United States 9 496 0.4× 690 0.7× 131 0.4× 16 0.1× 96 0.3× 10 1.3k
Kalpana Nattamai United States 14 740 0.6× 371 0.4× 178 0.6× 5 0.0× 259 0.9× 26 1.3k
Claes Båvik United States 15 825 0.6× 23 0.0× 104 0.3× 157 0.5× 163 0.6× 19 1.2k
Maria Mesuraca Italy 20 631 0.5× 155 0.2× 109 0.4× 9 0.0× 69 0.3× 41 966
L L Leung United States 9 335 0.3× 686 0.7× 88 0.3× 8 0.0× 86 0.3× 11 1.1k

Countries citing papers authored by N Balitrand

Since Specialization
Citations

This map shows the geographic impact of N Balitrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Balitrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Balitrand more than expected).

Fields of papers citing papers by N Balitrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Balitrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Balitrand. The network helps show where N Balitrand may publish in the future.

Co-authorship network of co-authors of N Balitrand

This figure shows the co-authorship network connecting the top 25 collaborators of N Balitrand. A scholar is included among the top collaborators of N Balitrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Balitrand. N Balitrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grelier, Aurore, Audrey Cras, N Balitrand, et al.. (2013). Toll-like receptor 3 regulates cord blood-derived endothelial cell function in vitro and in vivo. Angiogenesis. 16(4). 821–836. 16 indexed citations
2.
Pokorná, Kateřina, Martine Chopin, N Balitrand, et al.. (2012). Tracking the extramedullary PML-RARα-positive cell reservoirs in a preclinical model: Biomarker of long-term drug efficacy. Molecular and Cellular Probes. 27(1). 1–5. 4 indexed citations
3.
Cras, Audrey, N Balitrand, Pierre‐Yves Boëlle, et al.. (2011). Bexarotene via CBP/p300 Induces Suppression of NF-κB–Dependent Cell Growth and Invasion in Thyroid Cancer. Clinical Cancer Research. 18(2). 442–453. 27 indexed citations
4.
Cras, Audrey, N Balitrand, Bruno Cassinat, et al.. (2007). Epigenetic patterns of the retinoic acid receptor β2 promoter in retinoic acid-resistant thyroid cancer cells. Oncogene. 26(27). 4018–4024. 28 indexed citations
5.
6.
Bastié, Jean, N Balitrand, Fabien Guidez, et al.. (2004). 1α,25-Dihydroxyvitamin D3Transrepresses Retinoic Acid Transcriptional Activity via Vitamin D Receptor in Myeloid Cells. Molecular Endocrinology. 18(11). 2685–2699. 36 indexed citations
7.
Despouy, Gilles, Jean Bastié, N Balitrand, et al.. (2003). Cyclin D3 Is a Cofactor of Retinoic Acid Receptors, Modulating Their Activity in the Presence of Cellular Retinoic Acid-binding Protein II. Journal of Biological Chemistry. 278(8). 6355–6362. 35 indexed citations
8.
Cassinat, Bruno, Sylvie Chevret, Fabien Zassadowski, et al.. (2001). In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. Blood. 98(9). 2862–2864. 30 indexed citations
9.
Bastié, Jean, Gilles Despouy, N Balitrand, et al.. (2001). The novel co‐activator CRABPII binds to RARα and RXRα via two nuclear receptor interacting domains and does not require the AF‐2 ‘core’. FEBS Letters. 507(1). 67–73. 20 indexed citations
10.
Cassinat, Bruno, Fabien Zassadowski, N Balitrand, et al.. (2000). Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR. Leukemia. 14(2). 324–328. 105 indexed citations
11.
Silva, Nicolas Da, Sandrine Meyer‐Monard, Antonio Parrado, et al.. (2000). Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO. The Hematology Journal. 1(5). 316–328. 15 indexed citations
12.
Li, Yue, Bertrand Delpech, N Balitrand, et al.. (1999). Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nature Medicine. 5(6). 669–676. 134 indexed citations
13.
Carpentier, Alain, N Balitrand, Cécile Rochette‐Egly, et al.. (1997). Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers. Oncogene. 15(15). 1805–1813. 26 indexed citations
14.
Guidez, Fabien, Wenwen Huang, Jianhua Tong, et al.. (1994). Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.. PubMed. 8(2). 312–7. 65 indexed citations
15.
Barbey, S, et al.. (1992). 45. Regulation of BcI-2 and cell death by all-trans retinoic acid in acute promyelocytic leukemic cells. Biomedicine & Pharmacotherapy. 46(5-7). 260–260. 6 indexed citations
16.
Chomienne, Christine, N Balitrand, Paola Ballerini, et al.. (1991). All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.. Journal of Clinical Investigation. 88(6). 2150–2154. 64 indexed citations
17.
Chomienne, Christine, Paola Ballerini, N Balitrand, et al.. (1990). All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood. 76(9). 1710–1717. 14 indexed citations
18.
Najean, Y, et al.. (1984). A study of the efficacy of 5 alpha- and 5 beta-androstanes in chronic experimental aplastic anemia in mice.. PubMed. 26(6). 391–6. 2 indexed citations
19.
Dresch, C, A Faille, Odette Poirier, N Balitrand, & Y Najean. (1979). Hydroxyurea suicide study of the kinetic heterogeneity of colony forming cells in human bone marrow.. PubMed. 7(7). 337–44. 11 indexed citations
20.
Barrett, A. John, et al.. (1979). Bone marrow culture in aplastic anemia.. Journal of Clinical Pathology. 32(7). 660–665. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina R. Carpinelli Breakdown of academic impact, for papers by Mack Mabry Breakdown of academic impact, for papers by B Hazelton Breakdown of academic impact, for papers by Dapeng Wang Breakdown of academic impact, for papers by Janet Glassford Breakdown of academic impact, for papers by C C Reynolds Breakdown of academic impact, for papers by Kalpana Nattamai Breakdown of academic impact, for papers by Claes Båvik Breakdown of academic impact, for papers by Maria Mesuraca Breakdown of academic impact, for papers by L L Leung
Rankless by CCL
2026